Nutra Pharma Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Nutra Pharma Corp.

Nutra Pharma Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

Net Income before Extraordinaries

4,343.00

2,533.00

5,392.00

3,447.60

4,028.70

Depreciation, Depletion & Amortization

15.00

16.60

11.20

8.70

6.30

Other Funds

3,270.70

1,935.90

3,767.30

1,827.10

2,484.20

Funds from Operations

1,057.20

580.50

1,613.40

1,611.80

1,538.30

Changes in Working Capital

526.20

432.40

595.20

255.30

399.90

Net Operating Cash Flow

531.00

148.10

1,018.20

1,356.50

1,138.30

Capital Expenditures

21.60

0.70

3.40

9.10

Net Investing Cash Flow

21.60

0.70

3.40

9.10

Issuance/Reduction of Debt, Net

388.10

120.60

224.00

1,229.20

1,116.20

Net Financing Cash Flow

528.10

180.60

1,010.30

1,384.20

1,116.20

Net Change in Cash

2.90

10.90

8.60

24.40

31.20

Free Cash Flow

169.70

1,018.90

1,359.90

1,147.50

Change in Capital Stock

140.00

60.00

786.30

155.00

About Nutra Pharma

View Profile

Address	12538 West Atlantic Boulevard Coral Springs Florida 33071 United States
Employees	-
Website	http://www.nutrapharma.com
Updated	07/08/2019
Nutra Pharma Corp. is a biopharmaceutical company, which is engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies & homeopathic and ethical drugs for the management of pain, neurological disorders, autoimmune and infectious diseases. Its products are Cobroxin, which is used for an over-the-counter pain reliever designed to treat moderate to severe chronic pain and Nyloxin Extra Strength, which is used for stronger versions of Cobroxin. The company was founded on February 1, 2000 and is headquartered in Coral Springs, FL.